Attached files
| file | filename |
|---|---|
| 10-K - PVCT 10-K 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10k123109.htm |
| EX-31.2 - PVCT 10-K EX 31.2 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex31_2.htm |
| EX-32.1 - PVCT 10-K EX 32.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex32_1.htm |
| EX-31.1 - PVCT 10-K EX 31.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex31_1.htm |
| EX-21.1 - PVCT 10-K EX 21.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex21_1.htm |
EXHIBIT
23.1
Consent
of Independent
Registered
Public Accounting Firm
Provectus
Pharmaceuticals, Inc.
Knoxville,
Tennessee
We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (Nos. 333-99639, 333-86896, 333-73994 and 333-109354),
and on Form S-2 (Nos. 333-124951 and 333-119619) of Provectus Pharmaceuticals,
Inc. of our report dated March 31, 2010, relating to the consolidated financial
statements, which appears in this Form 10-K.
/s/ BDO Seidman, LLP
Chicago, Illinois
March 31, 2010